Julie Wei

Company: Ultragenyx Pharmaceutical Inc

Job title: Associate Director


CMC Considerations: Development of UX055 AAV Gene Therapy for CDKL5 Deficiency Disorder, a Rare Neurological Disorder 4:00 pm

Development of UX055 gene therapy using 2000L GMP Manufacturing Process Overcoming CMC Challenges for CNS administration Discussion of drug product formulation development, concentration and endotoxin control strategyRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.